使用Player FM应用程序离线!
21. Tyler Golato - VitaDAO, Longevity research & living to 1,000
已归档的系列专辑 ("不活跃的收取点" status)
When? This feed was archived on November 24, 2022 10:08 (). Last successful fetch was on June 09, 2022 09:18 ()
Why? 不活跃的收取点 status. 我们的伺服器已尝试了一段时间,但仍然无法截取有效的播客收取点
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 303489166 series 2988612
"Longevity has the potential to be to traditional medicine what crypto is to traditional finance." Balaji Srinivasan, 2021 (@balajis).
Tyler Golato is co-founder of VitaDAO, which is shifting the paradigm on the science of ageing by prioritising research into preventative and pre-emptive medical interventions.
Some longevity researchers contest that the first person to live to 1,000 is alive today. Tyler is more modest in his prediction but maintains that longevity research will unlock vast advancements in human life span.
Currently, it is more profitable for businesses to manage chronic conditions than to cure them leaving little incentive for longevity research funding. VitaDAO seeks to remedy this by offering a decentralised framework to fund, research, and commercialise longevity projects.
They are a decentralised community of academics, researchers, service providers and individuals that are utilising the DAO framework to democratise the BioPharma industry. The first of its kind, VitaDAO is a fascinating use case for future deployments of the model in the medical industry and beyond.
Tyler also goes into detail about his company Molecule (co-founded with Paul Kohlhaas (@paulkhls)), a framework that enables DAO revolution in Biopharma. Molecule aims to allow decentralised entities to interact with intellectual property to fractionalise it, effectively decentralising drug development.
Join this Koji Conversation, with Tyler Golato.
Join the Conversation:
Find Tyler on Twitter: @GolatoTyler
Twitter: @koji_capital
Website: koji.capital
Email: hello@koji.capital
Hosts: @Jack_Kji and @David_Kji
Discord: https://discord.gg/MThFGFfuRa
40集单集
已归档的系列专辑 ("不活跃的收取点" status)
When? This feed was archived on November 24, 2022 10:08 (). Last successful fetch was on June 09, 2022 09:18 ()
Why? 不活跃的收取点 status. 我们的伺服器已尝试了一段时间,但仍然无法截取有效的播客收取点
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 303489166 series 2988612
"Longevity has the potential to be to traditional medicine what crypto is to traditional finance." Balaji Srinivasan, 2021 (@balajis).
Tyler Golato is co-founder of VitaDAO, which is shifting the paradigm on the science of ageing by prioritising research into preventative and pre-emptive medical interventions.
Some longevity researchers contest that the first person to live to 1,000 is alive today. Tyler is more modest in his prediction but maintains that longevity research will unlock vast advancements in human life span.
Currently, it is more profitable for businesses to manage chronic conditions than to cure them leaving little incentive for longevity research funding. VitaDAO seeks to remedy this by offering a decentralised framework to fund, research, and commercialise longevity projects.
They are a decentralised community of academics, researchers, service providers and individuals that are utilising the DAO framework to democratise the BioPharma industry. The first of its kind, VitaDAO is a fascinating use case for future deployments of the model in the medical industry and beyond.
Tyler also goes into detail about his company Molecule (co-founded with Paul Kohlhaas (@paulkhls)), a framework that enables DAO revolution in Biopharma. Molecule aims to allow decentralised entities to interact with intellectual property to fractionalise it, effectively decentralising drug development.
Join this Koji Conversation, with Tyler Golato.
Join the Conversation:
Find Tyler on Twitter: @GolatoTyler
Twitter: @koji_capital
Website: koji.capital
Email: hello@koji.capital
Hosts: @Jack_Kji and @David_Kji
Discord: https://discord.gg/MThFGFfuRa
40集单集
Todos os episódios
×欢迎使用Player FM
Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。